Skip to content

Cannabis: all studies

Page 208 of 294: studies 2,071 to 2,080 of 2,937, newest first. Back to the cannabis overview

Research

Model Psychoses Induced by LSD-25 in Normals

A M A Archives of Neurology & Psychiatry June 1, 1956 Nicholas A. Bercel 35 citations

INTRODUCTION Experimental psychosis has a long history. It might have started with the administration of Cannabis indica boiling in wine to the ancient Hun warriors, resulting in mental obfuscation, as they were prepared for surgery because of wounds sustained in battle. Scientific experimental psychiatry began toward the end of the last century, in the Kraepelinian era—when the organic theory...

DOI: 10.1001/archneurpsyc.1956.02330240026003 (opens in new tab) Mescaline Cannabis Methaqualone Schizophrenia object-oriented programming +6

Set, setting and substance in ayahuasca ceremonies and their association with altered self-awareness experiences: An exploratory investigation

Discover Mental Health October 31, 2026 Rafael S. Rodrigues, Marcio S. C. Longo, Fernando R. Beserra et al.

Psychedelics, such as ayahuasca, have shown therapeutic potential and are known to alter self-awareness dimensions. Recent studies have focused on the antidepressant properties of ayahuasca, showing that changes in self-perception such as ego-dissolution and mystical experiences are related to therapeutic outcomes. However, limited research has addressed how the individual's mindset (set),...

PSYCHOACTIVE SUBSTANCES: THEIR CONNECTION TO TRANSCENDENT EXPERIENCES AND PSYCHOTIC PHENOMENA

Theophany October 25, 2026 Eleni Papamanou

This paper is a literature review with the aim of investigating the relationship between drug use and the occurrence of psychotic disorders/symptoms or transcendental experiences. The purpose of it is to analyze the historical evidence and scientific data that exist regarding the use of drugs in the occurrence of psychosis or transcendent experience. Initially, both the theoretical background...

Clinical characteristics of HHC-associated psychosis: an exploratory retrospective inpatient cohort study

Irish Journal of Psychological Medicine October 19, 2026 Sarah Lanigan, Níall Lally, Aoife Brett et al.

OBJECTIVES: To describe the demographic, clinical, and treatment characteristics of individuals admitted with hexahydrocannabinol (HHC)-associated psychosis and compare with cannabis-associated psychosis. METHODS: A retrospective chart review was undertaken of all admissions to the Adult Acute Mental Health Unit at University Hospital Galway, Ireland, between 1 May 2023 and 31 July 2025, with...

Beyond psychedelic exceptionalism: how people combine meditation with psychoactive substances, and how this relates to well-being.

Psychopharmacology October 17, 2026 Andreas Krabbe, Lena Lindström, Pilleriin Sikka et al.

Combining meditation with psychoactive substances is often assumed to be a niche practice centred on classic psychedelics. We sought to broaden this narrative in two cross-sectional studies. Study 1 used a broad naturalistic sample (N = 1,391) to examine the prevalence of substance use, meditation, and their simultaneous combination, as well as associations with subjective happiness. Study 2...

DOI: 10.1007/s00213-026-07179-5 (opens in new tab) Full text (opens in new tab) Meditation Polysubstance use Psychedelics Psychological flexibility +2

Synthetic Cannabinoids and the Purinergic–Dopaminergic Axis: P2x7 as a Candidate Primary Sensor of Neuroinflammatory Injury and the Role of Adenosine Receptor Heteromers in Emerging Nps Toxicity—A Hypothesis-Driven Integrative Review

Psychoactives October 15, 2026 Felipe Heemann

Synthetic cannabinoids (SCs), marketed as Spice, K2, and dozens of successor compounds, constitute one of the most pharmacologically dangerous categories of new psychoactive substances (NPS) currently in circulation. Their extreme toxicity relative to Δ9-tetrahydrocannabinol (THC) is not fully accounted for by CB1 receptor pharmacokinetics alone. This review proposes an integrative mechanistic...

Orgasmic Learning as a Treatment Framework for Female Orgasmic Disorder/Difficulty: A Review Using Perelman’s Sexual Tipping Point® Model

Current Sexual Health Reports October 7, 2026 Suzanne Mulvehill

Abstract Purpose of Review Female orgasmic disorder/difficulty (FOD) remains prevalent, yet treatments are limited and outcomes variable. Traditional approaches have focused primarily on stimulation, behavioral techniques, sex therapy, and psychological processes, without fully accounting for state-dependent and non-genital pathways through which orgasm may become accessible. These pathways may...

A wooden brazier and ritual plant burning in early Iron Age Xinjiang, China

npj Heritage Science October 3, 2026 Yuanchun Song, Yongqiang Wang, Yunpeng Tang et al.

This study aimed to investigate the function of a wooden brazier excavated from the Hongshan Cemetery (5th to 3rd century BC) in Xinjiang, northwestern China. Organic residues and material composition were analysed using gas chromatography-mass spectrometry (GC-MS) and wood anatomical analysis to identify burned plant resources and explore their cultural significance. GC-MS results confirmed...

Hallucinations: an overview from a homoeopathic perspective

International Journal of Homoeopathic Sciences October 1, 2026 Diyaana Z Crri, R Sakthi, R Samaran

Hallucinations are disturbances of perception in which a person experiences vivid sensory phenomena even though there is no corresponding external stimulus. They can involve different sensory modalities, including hearing voices or sounds, seeing people or objects, perceiving unusual smells or tastes, or experiencing sensations of touch or bodily movement. Although hallucinations are frequently...

Adverse reactions to psychedelics in naturalistic settings are associated with current psychopathology and well-being: A correlational study

Psychiatry Research October 1, 2026 Jaime Rojas-Hernández, Lucas F Borkel, Ángelo Santana Del Pino et al.

This study examines acute and delayed adverse reactions reported in naturalistic psychedelic use, focusing on their associations with substance-use patterns, contextual variables, and user motivations. Using an online survey incorporating the Psychedelic Use Scale, data were collected from a large naturalistic sample (N=1022) to analyze patterns of self-reported adverse reactions. Acute adverse...